Clinical trial
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
Recruiting now · Phase 2 · 1 countries · Registry ID NCT07589608
Recruiting nowPhase 2Interventional
What this study is about
The main purpose of this study, performed under the master protocol W8M-MC-CWMM (NCT06143956), is to examine the body weight-lowering efficacy and safety of macupatide plus eloralintide compared with placebo in participants with obesity or overweight and without type 2 diabetes. Participation will last about 64 weeks.
A promising-looking record is not the same as confirmed eligibility. The study team must review the full criteria and current recruitment status.
Basic eligibility
Age18 Years to 75 Years
SexAll
Healthy volunteersNot accepted
ConditionOverweight, Obesity
Full registry criteria
Inclusion Criteria: * See Master Protocol CWMM (NCT06143956) for inclusion criteria Exclusion Criteria: In addition to exclusion criteria in Master Protocol CWMM (NCT06143956): * Have type 1 diabetes or type 2 diabetes * Have an ongoing history of bradyarrhythmia and/or sinus bradycardia * Have an elevated resting pulse rate (greater than 100 bpm) or reduced resting pulse rate (less than 60 bpm) * Have a history of acute or chronic pancreatitis * All concomitant medications should be at a stable dose for at least 3 months prior to screening
Treatments and study arms
Macupatide
Drug
Administered SC
Eloralintide
Drug
Administered SC
Placebo
Drug
Administered SC
Primary outcomes
Percent Change from Baseline in Body WeightBaseline, Week 36
Study locations
40 locations were listed when this page was built. The first 40 are shown.
Dent Neurologic Institute🇺🇸 Amherst, New York, United States
Laszlo MechtlerPrincipal Investigator
The Institute for Liver Health II dba Arizona Clinical Trials - Mesa🇺🇸 Chandler, Arizona, United States
Yessica SachdevaPrincipal Investigator
Great Lakes Clinical Trials - Ravenswood🇺🇸 Chicago, Illinois, United States
Rupal TrivediPrincipal Investigator
CTI Clinical Research Center🇺🇸 Cincinnati, Ohio, United States
James MaynardPrincipal Investigator
StudyMetrix Research🇺🇸 City of Saint Peters, Missouri, United States
Timothy SmithPrincipal Investigator
FutureSearch Trials of Dallas🇺🇸 Dallas, Texas, United States
Michael DowningPrincipal Investigator
Sovah Clinical Research-River District🇺🇸 Danville, Virginia, United States
Stephan JannachPrincipal Investigator
NorCal Medical Research, Inc🇺🇸 Greenbrae, California, United States
Linda GaudianiPrincipal Investigator
Medication Management🇺🇸 Greensboro, North Carolina, United States
James FranklinPrincipal Investigator
Tribe Clinical Research, LLC🇺🇸 Greenville, South Carolina, United States
Ronald MayfieldPrincipal Investigator
PlanIt Research, PLLC🇺🇸 Houston, Texas, United States
Amer Al-KaradshehPrincipal Investigator
Velocity Clinical Research, Huntington Park🇺🇸 Huntington Park, California, United States
Stanley HsiaPrincipal Investigator
Las Vegas Medical Research🇺🇸 Las Vegas, Nevada, United States
Cornell CalinescuPrincipal Investigator
Monroe Biomedical Research - Louisville🇺🇸 Louisville, Kentucky, United States
Harold BaysPrincipal Investigator
New Horizon Research Center🇺🇸 Miami, Florida, United States
Lazaro NunezPrincipal Investigator
Indago Research & Health Center, Inc🇺🇸 Miami Lakes, Florida, United States
Jose CardonaPrincipal Investigator
Monroe Biomedical Research🇺🇸 Monroe, North Carolina, United States
Awawu IgbinadolorPrincipal Investigator
Lucas Research, Inc🇺🇸 Morehead City, North Carolina, United States
Kathryn LucasPrincipal Investigator
Quality Medical Research🇺🇸 Nashville, Tennessee, United States
Saras SharmaPrincipal Investigator
Lucida Clinical Trials🇺🇸 New Bedford, Massachusetts, United States
David ShihPrincipal Investigator
Lucas Research, Inc.🇺🇸 New Bern, North Carolina, United States
Joseph MaidesPrincipal Investigator
Suncoast Clinical Research, Inc.🇺🇸 New Port Richey, Florida, United States
Cathy BarnesPrincipal Investigator
Charter Research - Winter Park🇺🇸 Orlando, Florida, United States
Edgardo Rivera-RiveraPrincipal Investigator
Rochester Clinical Research, LLC🇺🇸 Rochester, New York, United States
Patrick ConnorsPrincipal Investigator
Peninsula Research Associates🇺🇸 Rolling Hills Estates, California, United States
LeighAnn SchmidtPrincipal Investigator
Endeavor Clinical Trials🇺🇸 San Antonio, Texas, United States
Nitendra AgarwalPrincipal Investigator
Headlands Research - Scottsdale🇺🇸 Scottsdale, Arizona, United States
Benjamin ClarkPrincipal Investigator
Headlands Research - Detroit🇺🇸 Southfield, Michigan, United States
Christopher RomeroPrincipal Investigator
Clinvest Headlands Llc🇺🇸 Springfield, Missouri, United States
Christina CappsPrincipal Investigator
Stamford Therapeutics Consortium🇺🇸 Stamford, Connecticut, United States
David RadinPrincipal Investigator
Charter Research - Lady Lake🇺🇸 The Villages, Florida, United States
Jeffrey NortonPrincipal Investigator
Cotton O'Neil Diabetes & Endocrinology🇺🇸 Topeka, Kansas, United States
susan brianPrincipal Investigator
Arcturus Healthcare , PLC, Troy Internal Medicine Research Division🇺🇸 Troy, Michigan, United States
Neil FraserPrincipal Investigator
The Institute for Liver Health II dba Arizona Liver Health-Tucson🇺🇸 Tucson, Arizona, United States
Anita KohliPrincipal Investigator
Diablo Clinical Research, Inc.🇺🇸 Walnut Creek, California, United States
Mark ChristiansenPrincipal Investigator
Central Washington Health Services Association d/b/a Confluence Health🇺🇸 Wenatchee, Washington, United States
Kathryn ErenPrincipal Investigator
Texas Valley Clinical Research🇺🇸 Weslaco, Texas, United States
Eduardo LunaPrincipal Investigator